Virtu Financial LLC Has $930,000 Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Virtu Financial LLC increased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 179.1% in the second quarter, Holdings Channel.com reports. The firm owned 39,008 shares of the construction company’s stock after buying an additional 25,031 shares during the quarter. Virtu Financial LLC’s holdings in Aspen Aerogels were worth $930,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Banque Cantonale Vaudoise increased its holdings in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares in the last quarter. nVerses Capital LLC acquired a new position in Aspen Aerogels in the 2nd quarter worth about $95,000. NorthCrest Asset Manangement LLC bought a new position in Aspen Aerogels in the second quarter valued at about $217,000. Victory Capital Management Inc. acquired a new stake in shares of Aspen Aerogels during the second quarter valued at about $230,000. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Aspen Aerogels by 15.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after purchasing an additional 1,938 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ASPN shares. TD Cowen lifted their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Benchmark reiterated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. Craig Hallum increased their price objective on Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a report on Friday, June 14th. HC Wainwright raised their target price on Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, Barclays began coverage on Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels currently has an average rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Price Performance

Shares of ASPN opened at $24.88 on Thursday. The firm has a market cap of $1.89 billion, a PE ratio of -56.55 and a beta of 2.16. Aspen Aerogels, Inc. has a 52-week low of $5.94 and a 52-week high of $33.15. The business’s 50 day moving average price is $24.84 and its two-hundred day moving average price is $23.09. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels’s quarterly revenue was up 144.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.22) EPS. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.21 EPS for the current year.

Insider Activity

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.